IL22 and psoriasis: Psoriasis is currently regarded as a systemic low-grade inflammation supported by a variety of cytokines, chemokines, and other inflammatory mediators including tumor necrosis factor (TNF)-α, interferon (IFN)-γ, interleukin (IL)-17, IL-22, IL-23, and IL-1β [4,5].